recent publications

• academic article

  • Reay, D. P., Yang, M., Watchko, J. F., Daood, M., O'Day, T. L., Rehman, K. K., Guttridge, D. C., Robbins, P. D., Clemens, P. R. Systemic delivery of NEMO binding domain/IKK gamma inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology Neurobiology of Disease  2011 43:598-608  DOI:10.1016/j.nbd.2011.05.008  PMID:21624467  PMCID:PMC3145633
  • Rybczynski, P. J., Zeck, R. E., Dudash, J., Combs, D. W., Burris, T. P., Yang, M., Osborne, M. C., Chen, X. L., Demarest, K. T. Benzoxazinones as ppar gamma agonists. 2. Sar of the amide substituent and in vivo results in a type 2 diabetes model Journal of Medicinal Chemistry  2004 47:196-209  DOI:10.1021/jm0301888  PMID:14695833
  • Rybczynski, P. J., Zeck, R. E., Combs, D. W., Turchi, I., Burris, T. P., Xu, J. Z., Yang, M., Demarest, K. T. Benzoxazinones as ppar gamma agonists. Part 1: Sar of three aromatic regions Bioorganic & Medicinal Chemistry Letters  2003 13:2359-2362  DOI:10.1016/s0960-894x(03)00401-3  PMID:12824034
  • Jung, F., Griffin, K. J., Song, W., Richardson, T. H., Yang, M., Johnson, E. F. Identification of amino acid substitutions that confer a high affinity for sulfaphenazole binding and a high catalytic efficiency for warfarin metabolism to P450 2C19 Biochemistry  1998 37:16270-16279  DOI:10.1021/bi981704c  PMID:9819219